January 15, 2021 SHARE Researchers at Washington University School of Medicine have received a $791,317 grant from the National Institutes of Health (NIH) to study factors that keep pregnant women from getting tested for COVID-19, to evaluate whether it is important to test women regularly during their pregnancies, and to determine whether pregnant women with COVID-19 need more specialized prenatal care. (Photo: Getty Images)
Pregnant women with COVID-19 face an increased risk of complications from the illness, including preterm birth, delivery by cesarean section, and, compared with other women of the same age, higher likelihood of death or admission to an intensive care unit.
Several financial tech companies that applied to become national banks are seeking exemptions from many provisions of the Community Reinvestment Act. A consumer advocacy group and the American Bankers Association say the OCC mustn't allow this.
Share this article
Share this article
BETHESDA, Maryland., Dec. 28, 2020 /PRNewswire-HISPANIC PR WIRE/ The National Institutes of Health has awarded eight research grants to develop approaches for identifying children at high risk for Multisystem Inflammatory Syndrome in Children (MIS-C), a rare and severe after-effect of COVID-19 or exposure to the virus that causes it. Up to $20 million will be provided for the projects over four years, pending the availability of funds. These awards underscore NIH s commitment to identifying children at risk for MIS-C, which will inform development of interventions to improve their health outcomes, said Diana Bianchi, M.D., director of NIH s
NIH to support radical approaches to nationwide COVID-19 testing and surveillance
RADx-rad program will fund non-traditional and repurposed technologies to combat the current pandemic and address future viral disease outbreaks.
The National Institutes of Health has awarded over $107 million to support new, non-traditional approaches and reimagined uses of existing tools to address gaps in COVID-19 testing and surveillance. The program also will develop platforms that can be deployed in future outbreaks of COVID-19 and other infectious diseases. A part of the Rapid Acceleration of Diagnostics (RADx) initiative, the awards from the RADx Radical (RADx-rad) program will support 49 research projects and grant supplements at 43 institutions across the United States. It will focus on non-traditional viral screening approaches, such as biological or physiological markers, new analytical platforms with novel chemistries or engineering, rapid detection strategies, point-of-care devices,
Awards part of a larger effort to study pediatric COVID-19 and related conditions.
The National Institutes of Health has awarded eight research grants to develop approaches for identifying children at high risk for Multisystem Inflammatory Syndrome in Children (MIS-C), a rare and severe after-effect of COVID-19 or exposure to the virus that causes it. Up to $20 million will be provided for the projects over four years, pending the availability of funds.
“These awards underscore NIH’s commitment to identifying children at risk for MIS-C, which will inform development of interventions to improve their health outcomes,” said Diana Bianchi, M.D., director of NIH’s